Publicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (17)

2016

  1. Serum levels of substance P and mortality in patients with a severe acute ischemic stroke

    International Journal of Molecular Sciences, Vol. 17, Núm. 6

2015

  1. Association between serum substance P levels and mortality in patients with severe sepsis

    Journal of Critical Care, Vol. 30, Núm. 5, pp. 924-928

  2. Association between serum total antioxidant capacity and mortality in severe septic patients

    Journal of Critical Care, Vol. 30, Núm. 1, pp. 217.e7-217.e12

  3. Serum substance p levels are associated with severity and mortality in patients with severe traumatic brain injury

    Critical Care, Vol. 19, Núm. 1

  4. Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury

    BMC Neurology, Vol. 15, Núm. 1

2014

  1. Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFβ1 from a bilayered alginate-PLGA scaffold

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 8, Núm. 7, pp. 521-533

2010

  1. Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: A case-control study

    Journal of Neuroimmunology, Vol. 227, Núm. 1-2, pp. 202-207

  2. Reticulated vitreous carbon: A useful material for cell adhesion and tissue invasion

    European Cells and Materials, Vol. 20, pp. 282-294

2007

  1. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene

    European Journal of Cancer, Vol. 43, Núm. 16, pp. 2373-2380

2006

  1. Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells

    Fertility and Sterility, Vol. 86, Núm. 6, pp. 1736-1743

  2. De Novo Autoimmune Hepatitis Following Liver Transplantation for Primary Biliary Cirrhosis

    Transplantation Proceedings, Vol. 38, Núm. 5, pp. 1467-1470

2005

  1. Justificación teórica del modelo lineal de Wagner para predecir la dosis de fármacos con cinética de eliminación de Michaelis-Menten

    Ciencia y Tecnologia Pharmaceutica, Vol. 15, Núm. 4, pp. 177-182

2004

  1. Farmacocinética de población del valproato: Influencia de la dosis y la comedicación

    Ciencia y Tecnologia Pharmaceutica, Vol. 14, Núm. 3, pp. 110-116

  2. Optimización del tratamiento con Carbamazepina: Efecto de la dosis, de la variabilidad interindividual y de la coadministración de otros fármacos

    Ciencia y Tecnologia Pharmaceutica, Vol. 14, Núm. 1, pp. 13-17

2002

  1. In vitro-in vivo characterization of gentamicin bone implants

    Journal of Controlled Release, Vol. 83, Núm. 3, pp. 353-364

1996

  1. Deletion of exon b3 of the BCR gene in CML: Easy breakpoint mapping by a two-round PCR

    Cancer Genetics and Cytogenetics, Vol. 91, Núm. 1, pp. 71-73

1995

  1. BCR‐ABL rearrangement and Variant’Philadelphia chromosome in de novo acute myelogenous leukaemia FAB subtype M1

    British Journal of Haematology, Vol. 91, Núm. 4, pp. 932-934